NCAM1: A Potential Biomarker for Charcot-Marie-Tooth Disease Progression
Researchers sought to identify biomarkers across different types of Charcot-Marie-Tooth disease by analyzing blood samples from both mouse models and patients.
Researchers sought to identify biomarkers across different types of Charcot-Marie-Tooth disease by analyzing blood samples from both mouse models and patients.
This review outlined clinical situations when diagnostic tests should be conducted for vitamin-responsive inherited diseases and when vitamins should be administered for optimal disease outcomes.
Gene therapy shows promise in the management of inherited peripheral neuropathy and the complex array of symptoms that patients experience. Gene therapy holds promise in the management of peripheral neuropathies and in significant improvement of quality of life for patients.
The measurement may provide a dynamic measure of axonal damage in a disease in which neuropathy is the only neurologic manifestation.